Us Bancorp »

Kymera Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-03-31 $123k 3.1k 40.20
2023-12-31 $76k 3.0k 25.46
2023-09-30 $4.1k 295 13.90
2023-06-30 $7.3k 318 22.99
2023-03-31 $8.7k 295 29.63
2022-12-31 $7.4k 295 24.96
2022-03-31 $9.0k 204 44.12